These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27798773)

  • 21. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience.
    Forster MR; Rashid OM; Perez MC; Choi J; Chaudhry T; Zager JS
    J Surg Oncol; 2014 Apr; 109(5):434-9. PubMed ID: 24249545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma.
    Modi S; Gibson T; Vigneswaran G; Patel S; Wheater M; Karydis I; Gupta S; Takhar A; Pearce N; Ottensmeier C; Stedman B
    Melanoma Res; 2022 Apr; 32(2):103-111. PubMed ID: 35254333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study.
    Vogl TJ; Koch SA; Lotz G; Gebauer B; Willinek W; Engelke C; Brüning R; Zeile M; Wacker F; Vogel A; Radeleff B; Scholtz JE
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):864-872. PubMed ID: 28144756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence.
    Vogel A; Ochsenreither S; Zager JS; Wacker F; Saborowski A
    Cancer Treat Rev; 2023 Feb; 113():102501. PubMed ID: 36587472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.
    Tong TML; Samim M; Kapiteijn E; Meijer TS; Speetjens FM; Brüning R; Schroeder TH; El-Sanosy S; Maschke H; Wacker FK; Vogel A; Dewald CLA; Goeman JJ; Burgmans MC
    Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1304-1313. PubMed ID: 35922562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
    Meijer TS; Dieters JHN; de Leede EM; de Geus-Oei LF; Vuijk J; Martini CH; van Erkel AR; Lutjeboer J; van der Meer RW; Tijl FGJ; Kapiteijn E; Vahrmeijer AL; Burgmans MC
    PLoS One; 2022; 17(1):e0261939. PubMed ID: 35025911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
    Hofmann H; von Haken R; Werner J; Kortes N; Bergmann F; Schemmer P; Jäger D; Radeleff B; Schulze-Bergkamen H
    Pancreatology; 2014; 14(6):546-9. PubMed ID: 25280592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option.
    Dewald CLA; Becker LS; Meine TC; Maschke SK; Wacker FK; Saborowski A; Vogel A; Hinrichs JB
    Clin Exp Metastasis; 2023 Feb; 40(1):95-104. PubMed ID: 36417096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
    Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
    Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemosaturation Percutaneous Hepatic Perfusion (CS-PHP) with Melphalan: Evaluation of 2D-Perfusion Angiography (2D-PA) for Leakage Detection of the Venous Double-Balloon Catheter.
    Dewald CLA; Meine TC; Winther HMB; Kloeckner R; Maschke SK; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Renne J; Hinrichs JB
    Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1441-1448. PubMed ID: 31089781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radial Artery Access for Hepatic Chemosaturation: The First Description of Technical Feasibility.
    Frost JP; Najran P; Bell J; Mullan D
    Cureus; 2021 Oct; 13(10):e18852. PubMed ID: 34671515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated hepatic perfusion for metastatic melanoma.
    Yamamoto M; Zager JS
    J Surg Oncol; 2014 Mar; 109(4):383-8. PubMed ID: 24166748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion.
    Rashid OM; Sloot S; Zager JS
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1355-64. PubMed ID: 25176398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.
    de Leede EM; Burgmans MC; Martini CH; Tijl FG; van Erkel AR; Vuyk J; Kapiteijn E; Verhoef C; van de Velde CJ; Vahrmeijer AL
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma.
    Meijer TS; Burgmans MC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):820-821. PubMed ID: 32683632
    [No Abstract]   [Full Text] [Related]  

  • 36. Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.
    Meijer TS; Geus-Oei LF; Martini CH; Tijl FGJ; Sitsen ME; Erkel ARV; Meer RWV; Kapiteijn E; Vahrmeijer AL; Burgmans MC
    Diagn Interv Radiol; 2019 Nov; 25(6):451-458. PubMed ID: 31650973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.
    Burgmans MC; de Leede EM; Martini CH; Kapiteijn E; Vahrmeijer AL; van Erkel AR
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):801-14. PubMed ID: 26718962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma.
    Chandrasekhar S; Perez M; Niaz Z; Ekram J; Lal N; Koly S; Cao B; Zager JS; Alomar M
    Cancer Control; 2024; 31():10732748241246898. PubMed ID: 38605434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors.
    Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Kuroda Y
    Int J Clin Oncol; 2002 Apr; 7(2):82-90. PubMed ID: 12018114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
    Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
    Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.